| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Biochemistry and Molecular Biology, School of Life Sciences, Faculty of Science, Australian National University, Canberra ACT 0200, Australia
Variants of the prototype Murray Valley encephalitis virus (MVE-1-51) were selected by serial plaque purification and amplification in monkey kidney (Vero) cells. Four clones (C1–C4) at passage levels two and nine (P2 and P9) were examined in 21-day-old Swiss outbred mice for neuroinvasiveness (assessed from LD50 values after intraperitoneal inoculation) and neurovirulence (LD50 values after intracranial inoculation). The growth characteristics of the clones were determined in intracranially inoculated mouse brain and in mouse neuroblastoma, Vero and mosquito (C6/36) cell lines. Genomic RNA of the cloned virus stocks was sequenced through the structural protein genes (E, prM/M and C) and the 5' untranslated region. Clone C2P2 was of high neuroinvasiveness whereas C2P9 was of low neuroinvasiveness; there were also decreased yields of C2P9 in C6/36 cells compared to C2P2 and MVE-1-51. These changes were associated with the substitution of valine for phenylalanine at amino acid position 141 of the C2P9 E protein. Clone C4P2 was of high neurovirulence and low neuroinvasiveness; C4P9 was of low neurovirulence, a change accompanied by a further reduction in neuroinvasiveness. Concomitantly, C4P9 showed a pronounced reduction in growth rates and yields in 21-day-old Swiss mouse brain, in mouse neuroblastoma cells and in C6/36 cells compared to parental virus. The phenotypic changes in clone 4 appear to be due to mutation(s) within non-structural protein genes.
* Author for correspondence. Present address: Department of Microbiology, Prince of Wales Hospital, High Street, Randwick, NSW 2031, Australia. Fax +61 2 398 4275.
Received 31 August 1994;
accepted 7 December 1994.
This article has been cited by other articles:
|
|
 |
|
  F. J. May, M. Lobigs, E. Lee, D. J. Gendle, J. S. Mackenzie, A. K. Broom, J. V. Conlan, and R. A. Hall Biological, antigenic and phylogenetic characterization of the flavivirus Alfuy J. Gen. Virol., February 1, 2006; 87(2): 329 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Song, N. Santi, O. Evensen, and V. N. Vakharia Molecular Determinants of Infectious Pancreatic Necrosis Virus Virulence and Cell Culture Adaptation J. Virol., August 15, 2005; 79(16): 10289 - 10299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Charlier, R. Molenkamp, P. Leyssen, J. Paeshuyse, C. Drosten, M. Panning, E. De Clercq, P. J. Bredenbeek, and J. Neyts Exchanging the Yellow Fever Virus Envelope Proteins with Modoc Virus prM and E Proteins Results in a Chimeric Virus That Is Neuroinvasive in SCID Mice J. Virol., July 15, 2004; 78(14): 7418 - 7426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Wallace, D. W. Smith, A. K. Broom, J. S. Mackenzie, R. A. Hall, G. R. Shellam, and P. C. McMinn Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice J. Gen. Virol., July 1, 2003; 84(7): 1723 - 1728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Charlier, P. Leyssen, J. Paeshuyse, C. Drosten, H. Schmitz, A. Van Lommel, E. De Clercq, and J. Neyts Infection of SCID mice with Montana Myotis leukoencephalitis virus as a model for flavivirus encephalitis J. Gen. Virol., August 1, 2002; 83(8): 1887 - 1896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Monath, J. Arroyo, I. Levenbook, Z.-X. Zhang, J. Catalan, K. Draper, and F. Guirakhoo Single Mutation in the Flavivirus Envelope Protein Hinge Region Increases Neurovirulence for Mice and Monkeys but Decreases Viscerotropism for Monkeys: Relevance to Development and Safety Testing of Live, Attenuated Vaccines J. Virol., February 15, 2002; 76(4): 1932 - 1943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Arroyo, F. Guirakhoo, S. Fenner, Z.-X. Zhang, T. P. Monath, and T. J. Chambers Molecular Basis for Attenuation of Neurovirulence of a Yellow Fever Virus/Japanese Encephalitis Virus Chimera Vaccine (ChimeriVax-JE) J. Virol., January 15, 2001; 75(2): 934 - 942. [Abstract] [Full Text]
|
|
|
|
|
|
S. Butrapet, C. Y.-H. Huang, D. J. Pierro, N. Bhamarapravati, D. J. Gubler, and R. M. Kinney Attenuation Markers of a Candidate Dengue Type 2 Vaccine Virus, Strain 16681 (PDK-53), Are Defined by Mutations in the 5' Noncoding Region and Nonstructural Proteins 1 and 3 J. Virol., April 1, 2000; 74(7): 3011 - 3019. [Abstract] [Full Text]
|
|
|
|
|
|
R. J. Hurrelbrink, A. Nestorowicz, and P. C. McMinn Characterization of infectious Murray Valley encephalitis virus derived from a stably cloned genome-length cDNA J. Gen. Virol., December 1, 1999; 80(12): 3115 - 3125. [Abstract] [Full Text]
|
|
|
|
|
|
R. Gualano, M. Pryor, M. Cauchi, P. Wright, and A. Davidson Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA J. Gen. Virol., March 1, 1998; 79(3): 437 - 446. [Abstract]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
